Past Updates from the Clinician Registry Listserv
Update Sent September 24, 2007
NOTE: This document is provided for historical purposes only and may not provide our most accurate and up-to-date information. The most current Clinician's information can be found on the Clinician Home Page.
Today's topics Include:
Travelers' Health
Ebola in Democratic Republic of the Congo - Sept. 18
The Ministry of Health of the Democratic Republic of the Congo (DRC) has announced the occurrence of an ongoing Ebola hemorrhagic fever outbreak in the Kasai-Occidental Province, a remote area of the country. Since the outbreak began a few weeks ago, several hundred people have become ill and over 100 deaths have been reported by the World Health Organization (WHO). The presence of Ebola virus has been confirmed in five patients and Salmonella typhi, the cause of acute typhoid fever, and Shigella dysenteriae in several other patients. Ongoing investigations are attempting to determine the extent of the Ebola outbreak.
http://wwwn.cdc.gov/travel/contentEbolaCongo.aspx
Outbreak Notice Update: Dengue, Tropical and Subtropical Regions - Sept. 19
Dengue has become one of the most common viral diseases transmitted to humans by the bite of infected mosquitoes (usually Aedes aegypti); it is the most common cause of fever in travelers returned from the Caribbean, Central America, and South Central Asia. Symptoms of dengue include fever, severe headache, retro-orbital eye pain (pain behind the eye), joint and muscle pain, and rash. Dengue can produce a range of illness from mild to severe, as well as fatal hemorrhagic fever. Travelers are at risk for dengue infection if they travel to or reside in areas where dengue virus is transmitted; the preventive measures outlined in the following link can reduce their risk.
http://wwwn.cdc.gov/travel/contentDengueTropicalSubTropical.aspx
Seasonal Influenza
FDA Approves Nasal Influenza Vaccine for Use in Younger Children - FDA News Release - Sept. 19The U.S. Food and Drug Administration approved expanding the population for use of the nasal influenza vaccine FluMist to include children between the ages of 2 and 5. Approval for the vaccine, which contains a weakened form of the live virus and is sprayed in the nose, was previously limited to healthy children 5 years of age and older and to adults up to age 49.
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01705.html
State-Specific Influenza Vaccination Coverage Among Adults Aged >18 Years - United States, 2003-04 and 2005-06 Influenza Seasons - MMWR Weekly - Sept. 21
Influenza epidemics occur seasonally and result in substantial morbidity and mortality among adults in the United States. This report describes the results of the analysis, which indicated that influenza vaccination coverage for the 2005-06 season did not return to levels observed before the vaccine shortage of 2004-05 and remained substantially below HP2010 targets. Comprehensive measures are needed to improve influenza vaccination coverage among adult populations in the United States, including increasing adoption of recommended adult immunization practices by health-care providers, raising public awareness about influenza vaccination, vaccinating throughout the influenza season, and ensuring stable supplies of readily available vaccine.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5637a1.htm
Influenza Vaccination Coverage Among Children Aged 6-59 Months - Six Immunization Information System Sentinel Sites, United States, 2006-07 Influenza Season - MMWR Weekly - Sept. 21
In June 2006, the Advisory Committee on Immunization Practices (ACIP) expanded its 2004 recommendation for routine influenza vaccination of children aged 6-23 months to include children aged 24-59 months. The 2006 ACIP recommendations also reemphasized that previously unvaccinated children aged <9 years should receive 2 doses of influenza vaccine administered at least 1 month apart to be fully vaccinated. In 2007, using data from six immunization information system (IIS) sentinel sites, CDC conducted the first assessment of influenza vaccination coverage among children aged 6-59 months during the 2006-07 influenza season. The findings demonstrated that, at all six sites, <30% of children aged 6-23 months and <20% of children aged 24-59 months were fully vaccinated.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5637a3.htm
Influenza Vaccination Coverage Among Children Aged 6-23 Months - United States, 2005-06 Influenza Season - MMWR Weekly - Sept. 21
This report describes the results of analysis, which indicated that 31.9% of children in this age group received at least 1 dose of influenza vaccine and 20.6% were fully vaccinated according to ACIP recommendations; however, results varied substantially among states.
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5637a2.htm
"Emergency Preparedness and You"
New section of emergency.cdc.gov: "Emergency Preparedness and You"
The possibility of public health emergencies arising in the United States concerns many people in the wake of recent hurricanes, tsunamis, acts of terrorism, and the threat of pandemic influenza. Though some people feel it is impossible to be prepared for unexpected events, the truth is that taking preparedness actions helps people deal with disasters of all sorts much more effectively when they do occur. To help, Centers for Disease Control and Prevention (CDC) and the American Red Cross have teamed up to answer common questions and provide step by step guidance you can take now to protect you and your loved ones.
http://emergency.cdc.gov/preparedness/
The CDC and HHS logos are the exclusive property of the Department of Health and Human Services and may not be used for any purpose without prior express written permission. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
Links to non-Federal organizations are provided solely as a service to our users. Links do not constitute an endorsement of any organization by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organizations.
Please visit the COCA web page for additional information: http://www.bt.cdc.gov/coca/.
Our Clinician Communication Team is committed to excellence in reporting our weekly updates. Please e-mail coca@cdc.gov should you note any written errors or discrepancies.
If you need to unsubscribe or update your information, please go to our website: http://www.bt.cdc.gov/clinregistry
If you need further information or technical help, please send an e-mail message to: coca@cdc.gov
- Page last updated September 24, 2007
- Content source: CDC Emergency Communication System (ECS), Division of Health Communication and Marketing (DHCM), National Center for Health Marketing (NCHM)
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov
